Skip to main content
logo
PT Prodia Diagnostic Line Tbk (IDX:PRDL)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
254.00
+2.00 (0.79%)
Last updated: Sep 2, 2026, 11:59 AM WIB

IDX:PRDL Financials Overview

Millions IDR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Revenue
59,59474,37158,656111,779
Revenue Growth
-46.69%26.79%-47.52%-
Gross Profit
29,11643,01530,93773,565
Operating Income
8,59324,77615,00148,251
Net Income
2,83616,9899,99835,776
Earnings Per Share
2.3213.938.1929.32
EPS Growth
-92.07%69.93%-72.05%-

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Clinical Chemistry
42,55560,38150,59293,989
Hematology
3,7554,0861,06293.03
Instrument
12,5018,8266,89316,532
Immunology & Biomoleculer
40.3456.5725.59962.88
Services
742.651,02283.3202
Total
59,59474,37158,656111,779

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Cash & Investments
1,69910,80329,45828,659
Total Debt
99,34294,300102,40848,767
Net Cash (Debt)
-97,644-83,497-72,951-20,108
Net Cash Growth
----
Net Cash Per Share
-80.04-68.44-59.80-16.48

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
20,14321,787-3,96231,797
Capital Expenditures
-24,717-30,576-49,288-49,144
Free Cash Flow
-4,574-8,789-53,249-17,347
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Gross Margin
48.86%57.84%52.74%65.81%
Operating Margin
14.42%33.31%25.57%43.17%
Pretax Margin
10.99%30.28%22.82%42.17%
Profit Margin
4.76%22.84%17.04%32.01%
FCF Margin
-7.67%-11.82%-90.78%-15.52%